First report of Candida auris in Romania: clinical and molecular aspects.


Journal

Antimicrobial resistance and infection control
ISSN: 2047-2994
Titre abrégé: Antimicrob Resist Infect Control
Pays: England
ID NLM: 101585411

Informations de publication

Date de publication:
07 09 2023
Historique:
received: 23 06 2023
accepted: 26 08 2023
medline: 8 9 2023
pubmed: 7 9 2023
entrez: 6 9 2023
Statut: epublish

Résumé

The emerging opportunistic fungal pathogen Candida auris raises significant concerns for public health due to its outbreak potential, the associated high mortality, increased resistance to antifungals, challenging identification to species level, since commonly used diagnostic methods can confuse this fungus with other Candida spp. The present outbreak report describes probably some of the first Candida auris cases in Romania, providing clinical and epidemiological data, and also whole genome sequencing data. The cases were identified in three hospitals in Bucharest during the first eight months of 2022.

Identifiants

pubmed: 37674189
doi: 10.1186/s13756-023-01297-x
pii: 10.1186/s13756-023-01297-x
pmc: PMC10483769
doi:

Substances chimiques

Antifungal Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

91

Informations de copyright

© 2023. BioMed Central Ltd., part of Springer Nature.

Références

Clin Infect Dis. 2017 Jan 15;64(2):134-140
pubmed: 27988485
Am J Transplant. 2017 Jan;17(1):296-299
pubmed: 28029734
Antimicrob Resist Infect Control. 2016 Oct 19;5:35
pubmed: 27777756
PLoS Pathog. 2017 May 18;13(5):e1006290
pubmed: 28542486
Emerg Infect Dis. 2023 Jul;29(7):1297-1301
pubmed: 37347492
Microbiol Spectr. 2022 Apr 27;10(2):e0063422
pubmed: 35343775
J Clin Microbiol. 2015 Jun;53(6):1823-30
pubmed: 25809970
Annu Rev Microbiol. 2023 Sep 15;77:583-602
pubmed: 37406342
Med Mycol. 2019 Jan 1;57(1):1-12
pubmed: 30085270
Mycoses. 2018 Jul;61(7):498-505
pubmed: 29655180
J Infect. 2016 Oct;73(4):369-74
pubmed: 27452195
Emerg Infect Dis. 2013 Oct;19(10):1670-3
pubmed: 24048006
Microbiol Res. 2021 Jan;242:126621
pubmed: 33096325
Emerg Infect Dis. 2017 Jan;23(1):162-164
pubmed: 27983941
Microbiologyopen. 2018 Aug;7(4):e00578
pubmed: 29345117
J Mol Biol. 1990 Oct 5;215(3):403-10
pubmed: 2231712
Mycoses. 2022 Jul;65(7):683-703
pubmed: 35555921

Auteurs

Adriana Mihaela Stanciu (AM)

"Carol Davila" University of Medicine and Pharmacy, Dionisie Lupu Street no 37, Bucharest, 050474, Romania.
"Prof. Dr. Matei Bals" National Institute of Infectious Diseases, Calistrat Grozovici Street no 1, Bucharest, 021105, Romania.

Dragoș Florea (D)

"Carol Davila" University of Medicine and Pharmacy, Dionisie Lupu Street no 37, Bucharest, 050474, Romania. dflorea2002@yahoo.com.
"Prof. Dr. Matei Bals" National Institute of Infectious Diseases, Calistrat Grozovici Street no 1, Bucharest, 021105, Romania. dflorea2002@yahoo.com.

Marius Surleac (M)

"Prof. Dr. Matei Bals" National Institute of Infectious Diseases, Calistrat Grozovici Street no 1, Bucharest, 021105, Romania.

Simona Paraschiv (S)

"Carol Davila" University of Medicine and Pharmacy, Dionisie Lupu Street no 37, Bucharest, 050474, Romania.
"Prof. Dr. Matei Bals" National Institute of Infectious Diseases, Calistrat Grozovici Street no 1, Bucharest, 021105, Romania.

Dan Oțelea (D)

"Prof. Dr. Matei Bals" National Institute of Infectious Diseases, Calistrat Grozovici Street no 1, Bucharest, 021105, Romania.

Daniela Tălăpan (D)

"Carol Davila" University of Medicine and Pharmacy, Dionisie Lupu Street no 37, Bucharest, 050474, Romania.
"Prof. Dr. Matei Bals" National Institute of Infectious Diseases, Calistrat Grozovici Street no 1, Bucharest, 021105, Romania.

Gabriel Adrian Popescu (GA)

"Carol Davila" University of Medicine and Pharmacy, Dionisie Lupu Street no 37, Bucharest, 050474, Romania.
"Prof. Dr. Matei Bals" National Institute of Infectious Diseases, Calistrat Grozovici Street no 1, Bucharest, 021105, Romania.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH